{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:49:39Z","timestamp":1787222979420,"version":"build-2736575974"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Biotechnology Project","award":["BT\/PR16356\/BID\/7\/596\/2016"],"award-info":[{"award-number":["BT\/PR16356\/BID\/7\/596\/2016"]}]},{"name":"Ministry of Science and Technology, Government of India"},{"name":"Turing-Roche Strategic Partnership"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The traditional method of drug reuse or repurposing has significantly contributed to the identification of new antiviral compounds and therapeutic targets, enabling rapid response to developing infectious illnesses. This article presents an overview of how modern computational methods are used in drug repurposing for the treatment of viral infectious diseases. These methods utilize data sets that include reviewed information on the host\u2019s response to pathogens and drugs, as well as various connections such as gene expression patterns and protein\u2013protein interaction networks. We assess the potential benefits and limitations of these methods by examining monkeypox as a specific example, but the knowledge acquired can be applied to other comparable disease scenarios.<\/jats:p>","DOI":"10.1093\/bfgp\/elad058","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T05:58:10Z","timestamp":1704520690000},"page":"570-578","source":"Crossref","is-referenced-by-count":8,"title":["Computational drug repurposing for viral infectious diseases: a case study on monkeypox"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-8656","authenticated-orcid":false,"given":"Sovan","family":"Saha","sequence":"first","affiliation":[{"name":"Department of Computer Science and Engineering (Artificial Intelligence and Machine Learning), Techno Main Salt Lake , EM-4\/1, Sector V, Bidhannagar, Kolkata, West Bengal 700091 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyali","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Engineering, Netaji Subhash Engineering College , Garia, Kolkata-700152 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mita","family":"Nasipuri","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Engineering, Jadavpur University , Kolkata - 700032 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadip","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Engineering, Jadavpur University , Kolkata - 700032 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapabrata","family":"Chakraborti","sequence":"additional","affiliation":[{"name":"Department of Medical Physics and Biomedical Engineering, University College London ,","place":["UK"]},{"name":"Health Science Programme, The Alan Turing Institute , London ,","place":["UK"]},{"name":"Linacre College, University of Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"2024092711575420300_ref1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2024092711575420300_ref2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2024092711575420300_ref3","first-page":"2015","article-title":"Drug repositioning: a review","volume-title":"International Journal of Pharma Research & Review","author":"Deotarse","year":"2015"},{"key":"2024092711575420300_ref4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jtos.2020.11.012","article-title":"Repurposing medications","volume":"19","author":"Novack","year":"2020","journal-title":"Ocul Surf"},{"key":"2024092711575420300_ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd.2018.92","article-title":"Overcoming the legal and regulatory barriers to drug repurposing","volume":"18","author":"Breckenridge","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2024092711575420300_ref6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1358\/dnp.2010.23.1.1440373","article-title":"The Year's new drugs & biologics - 2009","volume":"23","author":"Graul","year":"2010","journal-title":"Drug News Perspect"},{"key":"2024092711575420300_ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1377\/hlthaff.2014.1038","article-title":"The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs","volume":"34","author":"Kesselheim","year":"2015","journal-title":"Health Aff"},{"key":"2024092711575420300_ref8","author":"Opportunities to repurpose medicines in the NHS"},{"key":"2024092711575420300_ref9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1358\/dot.2020.56.1.3129707","article-title":"The year's new drugs and biologics 2019","volume":"56","author":"Graul","year":"2020","journal-title":"Drugs Today"},{"key":"2024092711575420300_ref10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1358\/dot.2021.57.2.3275929","article-title":"The year's new drugs and biologics 2020","volume":"57","author":"Graul","year":"2021","journal-title":"Drugs Today"},{"key":"2024092711575420300_ref11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"2024092711575420300_ref12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00273","article-title":"Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics","volume":"7","author":"Hernandez","year":"2017","journal-title":"Front Oncol"},{"key":"2024092711575420300_ref13","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.3390\/app10155076","article-title":"Computational drug repositioning: current progress and challenges","volume":"10","author":"Ko","year":"2020","journal-title":"Appl Sci"},{"key":"2024092711575420300_ref14","author":"PubMed"},{"key":"2024092711575420300_ref15","doi-asserted-by":"crossref","first-page":"D351","DOI":"10.1093\/nar\/gkm843","article-title":"ChemBank: a small-molecule screening and cheminformatics resource database","volume":"36","author":"Seiler","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref16","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref17","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","article-title":"GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support","volume":"14","author":"Rebhan","year":"1998","journal-title":"Bioinformatics"},{"key":"2024092711575420300_ref19","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref20","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref21","doi-asserted-by":"crossref","first-page":"D932","DOI":"10.1093\/nar\/gkw993","article-title":"DrugCentral: online drug compendium","volume":"45","author":"Ursu","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref22","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2024092711575420300_ref23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2024092711575420300_ref24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cels.2017.11.001","article-title":"The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations","volume":"6","author":"Keenan","year":"2018","journal-title":"Cell Syst"},{"key":"2024092711575420300_ref25","doi-asserted-by":"crossref","first-page":"D558","DOI":"10.1093\/nar\/gkx1063","article-title":"Data portal for the library of integrated network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data","volume":"46","author":"Koleti","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2024092711575420300_ref27","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jm300576q","article-title":"Predicting new indications for approved drugs using a proteochemometric method","volume":"55","author":"Dakshanamurthy","year":"2012","journal-title":"J Med Chem"},{"key":"2024092711575420300_ref28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.drudis.2015.08.003","article-title":"Structures of G protein-coupled receptors reveal new opportunities for drug discovery","volume":"20","author":"Cooke","year":"2015","journal-title":"Drug Discov Today"},{"key":"2024092711575420300_ref29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymeth.2021.08.007","article-title":"Drug repurposing for COVID-19 using computational screening: is Fostamatinib\/R406 a potential candidate?","volume":"203","author":"Saha","year":"2022","journal-title":"Methods"},{"key":"2024092711575420300_ref30","article-title":"ML-DTD: machine learning-based drug target discovery for the potential treatment of COVID-19","volume":"10","author":"Saha","year":"2022","journal-title":"Vaccine"},{"key":"2024092711575420300_ref31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.4161\/auto.6.8.13551","article-title":"Identification of small molecules enhancing autophagic function from drug network analysis","volume":"6","author":"Iorio","year":"2010","journal-title":"Autophagy"},{"key":"2024092711575420300_ref32","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1158140","article-title":"Drug target identification using side-effect similarity","volume":"321","author":"Campillos","year":"2008","journal-title":"Science"},{"key":"2024092711575420300_ref34","article-title":"Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis","volume":"7","author":"Smith","year":"2012","journal-title":"PloS One"},{"key":"2024092711575420300_ref35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1752-0509-7-139","article-title":"Network based elucidation of drug response: from modulators to targets","volume":"7","author":"Iorio","year":"2013","journal-title":"BMC Syst Biol"},{"key":"2024092711575420300_ref36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3259","article-title":"Understanding multicellular function and disease with human tissue-specific networks","volume":"47","author":"Greene","year":"2015","journal-title":"Nat Genet"},{"key":"2024092711575420300_ref37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","article-title":"Use of genome-wide association studies for drug repositioning","volume":"30","author":"Sanseau","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2024092711575420300_ref38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1755-8794-8-S2-S1","article-title":"Novel therapeutics for coronary artery disease from genome-wide association study data","volume":"8","author":"Grover","year":"2015","journal-title":"BMC Med Genomics"},{"key":"2024092711575420300_ref39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/d41586-018-05462-w","article-title":"New human gene tally reignites debate","volume":"558","author":"Willyard","year":"2018","journal-title":"Nature"},{"key":"2024092711575420300_ref40","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/nbt.2758","article-title":"Rational drug repositioning by medical genetics","volume":"31","author":"Wang","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2024092711575420300_ref41","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat Genet"},{"key":"2024092711575420300_ref42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"key":"2024092711575420300_ref43","article-title":"Detecting overlapping protein complexes by rough-fuzzy clustering in protein-protein interaction networks","volume":"9","author":"Wu","year":"2014","journal-title":"PloS One"},{"key":"2024092711575420300_ref44","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1755-8794-8-S2-S2","article-title":"Inferring drug-disease associations based on known protein complexes","volume":"8","author":"Yu","year":"2015","journal-title":"BMC Med Genomics"},{"key":"2024092711575420300_ref45","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/bioinformatics\/btw228","article-title":"Drug repositioning based on comprehensive similarity measures and bi-random walk algorithm","volume":"32","author":"Luo","year":"2016","journal-title":"Bioinformatics"},{"key":"2024092711575420300_ref46","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/07391102.2015.1060161","article-title":"Identification of new candidate drugs for lung cancer using chemical\u2013chemical interactions, chemical\u2013protein interactions and a K-means clustering algorithm","volume":"34","author":"Lu","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"2024092711575420300_ref47","doi-asserted-by":"crossref","first-page":"036103","DOI":"10.1103\/PhysRevE.83.036103","article-title":"Unfolding communities in large complex networks: combining defensive and offensive label propagation for core extraction","volume":"83","author":"Subelj","year":"2011","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"key":"2024092711575420300_ref48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000641","article-title":"Associating genes and protein complexes with disease via network propagation","volume":"6","author":"Vanunu","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"2024092711575420300_ref49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000450","article-title":"Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts","volume":"5","author":"Li","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"2024092711575420300_ref50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060618","article-title":"Drug target prediction and repositioning using an integrated network-based approach","volume":"8","author":"Emig","year":"2013","journal-title":"PloS One"},{"key":"2024092711575420300_ref51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.artmed.2014.11.003","article-title":"DrugNet: network-based drug\u2013disease prioritization by integrating heterogeneous data","volume":"63","author":"Mart\u00ednez","year":"2015","journal-title":"Artif Intell Med"},{"key":"2024092711575420300_ref52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2024092711575420300_ref53","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jiph.2023.03.004","article-title":"Molecular docking of monkeypox (MPOX) virus proteinase with FDA approved lead molecules","volume":"16","author":"Arasu","year":"2023","journal-title":"J Infect Public Health"},{"key":"2024092711575420300_ref54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","article-title":"Monkeypox virus and insights into its immunomodulatory proteins","volume":"225","author":"Weaver","year":"2008","journal-title":"Immunol Rev"},{"key":"2024092711575420300_ref55","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1080\/22221751.2022.2095309","article-title":"Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters","volume":"11","author":"Xiang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"2024092711575420300_ref56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo Basin","volume":"340","author":"Chen","year":"2005","journal-title":"Virology"},{"key":"2024092711575420300_ref57","doi-asserted-by":"crossref","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","article-title":"Status of human monkeypox: clinical disease, epidemiology and research","volume":"29","author":"Damon","year":"2011","journal-title":"Vaccine"},{"issue":"16","key":"2024092711575420300_ref58","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules27165277","article-title":"In silico repurposed drugs against monkeypox virus","volume":"27","author":"Lam","year":"2022","journal-title":"Molecules"},{"key":"2024092711575420300_ref59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.028","article-title":"Transmission of monkeypox virus through sexual contact; a novel route of infection","volume":"85","author":"Heskin","year":"2022","journal-title":"J Infect"},{"key":"2024092711575420300_ref60","article-title":"Ancient gene capture and recent gene loss shape the evolution of orthopoxvirus-host interaction genes","volume":"12","author":"Senkevich, Tatiana","year":"2021","journal-title":"MBio"},{"key":"2024092711575420300_ref61","volume-title":"Fields Virology","author":"Fields","year":"2013"},{"key":"2024092711575420300_ref62","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010199","article-title":"Poxvirus DNA replication","volume-title":"Cold Spring Harbor Perspectives in Biology","author":"Moss"},{"key":"2024092711575420300_ref63","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/mcp.M117.067116","article-title":"Identifying host factors associated with DNA replicated during virus infection","volume":"16","author":"Reyes","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"2024092711575420300_ref64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","article-title":"Human monkeypox: an emerging zoonosis","volume":"4","author":"Di Giulio","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"2024092711575420300_ref65","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024092711575420300_ref66","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/infdis\/jiab133","article-title":"Clinical and epidemiological findings from enhanced monkeypox surveillance in Tshuapa Province, Democratic Republic of the Congo during 2011\u20132015","volume":"223","author":"Whitehouse","year":"2021","journal-title":"J Infect Dis"},{"key":"2024092711575420300_ref67","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4014\/jmb.2306.06033","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for the re-emerging human monkeypox virus","volume":"33","author":"Lee","year":"2023","journal-title":"J Microbiol Biotechnol"},{"key":"2024092711575420300_ref68","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"The UniProt C","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2024092711575420300_ref69","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcc.25780","article-title":"PPI-detect: a support vector machine model for sequence-based prediction of protein\u2013protein interactions","volume":"40","author":"Romero-Molina","year":"2019","journal-title":"J Comput Chem"},{"key":"2024092711575420300_ref70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fmicb.2017.01557","article-title":"Protein\u2013protein interactions in virus\u2013host systems","volume":"8","author":"Brito","year":"2017","journal-title":"Front Microbiol"},{"key":"2024092711575420300_ref71","first-page":"441","article-title":"Analysis of protein targets in pathogen\u2013host interaction in infectious diseases: a case study on Plasmodium falciparum and Homo sapiens interaction network","volume":"17","author":"Saha","year":"2018","journal-title":"Brief Funct Genomics"},{"key":"2024092711575420300_ref72","first-page":"1147","article-title":"Identifying influential spreaders based on edge ratio and neighborhood diversity measures in complex networks","volume":"101","author":"Samadi","year":"2019","journal-title":"Comput Secur"},{"key":"2024092711575420300_ref73","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12117","article-title":"Detection of spreader nodes in human-SARS-CoV protein-protein interaction network","volume":"9","author":"Saha","year":"2021","journal-title":"PeerJ"},{"key":"2024092711575420300_ref74","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1186\/1477-5956-11-S1-S18","article-title":"Detecting overlapping protein complexes in PPI networks based on robustness","volume":"11","author":"Wang","year":"2013","journal-title":"Proteome Sci"},{"key":"2024092711575420300_ref75","author":"Fostamatinib-DrugBank"},{"key":"2024092711575420300_ref76","author":"NADH-DrugBank"},{"key":"2024092711575420300_ref77","author":"Glutamic Acid-DrugBank"},{"key":"2024092711575420300_ref78","author":"Copper-DrugBank"},{"key":"2024092711575420300_ref79","author":"Zinc-Chloride-DrugBank"},{"key":"2024092711575420300_ref80","author":"Zinc-DrugBank"},{"key":"2024092711575420300_ref81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1116988","article-title":"Deciphering the complete human-monkeypox virus interactome: identifying immune responses and potential drug targets","volume":"14","author":"Kataria","year":"2023","journal-title":"Front Immunol"},{"key":"2024092711575420300_ref82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jhin.2022.06.012","article-title":"Efficacy of biocidal agents and disinfectants against the monkeypox virus and other orthopoxviruses","volume":"127","author":"Kampf","year":"2022","journal-title":"J Hosp Infect"},{"key":"2024092711575420300_ref83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s15010-022-01874-z","article-title":"Clinical and virological features of first human monkeypox cases in Germany","volume":"51","author":"Noe","year":"2023","journal-title":"Infection"},{"key":"2024092711575420300_ref84","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1128\/JVI.03134-13","article-title":"Vaccinia virus requires glutamine but not glucose for efficient replication","volume":"88","author":"Fontaine Krystal","year":"2014","journal-title":"J Virol"},{"key":"2024092711575420300_ref85","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1042\/BCJ20210181","article-title":"NAD+-consuming enzymes in immune defense against viral infection","volume":"478","author":"Shang","year":"2021","journal-title":"Biochem J"}],"container-title":["Briefings in Functional Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/23\/5\/570\/59370544\/elad058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/23\/5\/570\/59370544\/elad058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:59:04Z","timestamp":1727438344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bfg\/article\/23\/5\/570\/7512001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,1,5]]},"published-print":{"date-parts":[[2024,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/bfgp\/elad058","relation":{},"ISSN":["2041-2649","2041-2657"],"issn-type":[{"value":"2041-2649","type":"print"},{"value":"2041-2657","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,1,5]]}}}